Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Padilla, Eduardo
1027  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Pseudomonas aeruginosa antibiotic susceptibility profiles, ..:

Quesada, Maria Dolores ; Wang, Yun Hao ; Pitart, Cristina...
The Lancet Regional Health - Europe.  , 2023
Link: https://ddd.uab.cat/reco..
 
?
2

ESARDA Bulletin Vol. 65:

BOGDANOFF Ville ; PERÄJÄRVI Kari ; PADILLA Eduardo...
JRC136479.  , 2023
Link: https://publications.jrc..
 
?
3

Comparison of Ceftolozane/Tazobactam Infusion Regimens in a..:

Montero, María Milagro ; Domene-Ochoa, Sandra ; López-Causapé, Carla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241897/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Antibody production and immunoassay development for the det..:

Cotrina, Ellen ; Rodriguez, Montserrat ; García, Astrid...
Sí.  , 2022
Link: http://hdl.handle.net/10..
 
?
5

ATP Bioluminescence Assay To Evaluate Antibiotic Combinatio..:

Puig-Collderram, Berta ; Domene-Ochoa, Sandra ; Salvà-Comas, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431428/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Antibody production and immunoassay development for the det..:

Cotrina, Ellen ; Rodriguez, Montserrat ; García, Astrid...
Sí.  , 2022
Link: http://hdl.handle.net/10..
 
?
7

Aminoglycoside or Polymyxin Monotherapy for Treating Compli..:

López-Montesinos, Inmaculada ; Gómez-Zorrilla, Silvia ; Palacios-Baena, Zaira Raquel...
Publisher's version.  , 2022
Link: http://hdl.handle.net/10..
 
?
8

Assessment of human IgG response with a fluorescent peptide..:

Guercetti, Julián ; Sappia, Luciano ; Alorda, Marc...
Sí.  , 2022
Link: http://hdl.handle.net/10..
 
?
9

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI..:

Lopez-Montesinos, Inmaculada ; Montero, María Milagro ; Domene-Ochoa, Sandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686790/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Epidemiological characteristics and outcomes of COVID-19 ca..:

Politi, Julieta ; Martín-Sánchez, Mario ; Mercuriali, Lilas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138960/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Aminoglycoside or Polymyxin Monotherapy for Treating Compli..:

López Montesinos, Inmaculada ; Gómez-Zorrilla, Silvia ; Palacios-Baena, Zaira Raquel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847631/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Risk Factors for Amoxicillin-Clavulanate Resistance in Comm..:

Martínez-Casanova, Javier ; Gómez-Zorrilla, Silvia ; Prim, Nuria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156637/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Time-Kill Evaluation of Antibiotic Combinations Containing ..:

Montero, Maria M ; Domene Ochoa, Sandra ; López-Causapé, Carla...
9;1.  , 2021
Link: http://hdl.handle.net/10..
 
?
14

Time-Kill Evaluation of Antibiotic Combinations Containing ..:

Montero, María M ; Domene Ochoa, Sandra ; López-Causapé, Carla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552783/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Impact of ceftolozane/tazobactam concentrations in continuo..:

Montero, María M ; Domene-Ochoa, Sandra ; López-Causapé, Carla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589991/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15